Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
247.6 EUR | +0.81% | -.--% | -.--% |
Sales 2024 * | 60.06B 66.4B 61.61B 5,532B | Sales 2025 * | 63.84B 70.57B 65.48B 5,880B | Capitalization | 173B 191B 177B 15,920B |
---|---|---|---|---|---|
Net income 2024 * | 13.32B 14.73B 13.66B 1,227B | Net income 2025 * | 14.75B 16.31B 15.13B 1,359B | EV / Sales 2024 * | 3.11 x |
Net Debt 2024 * | 14.24B 15.74B 14.61B 1,312B | Net Debt 2025 * | 8.16B 9.03B 8.37B 752B | EV / Sales 2025 * | 2.84 x |
P/E ratio 2024 * |
12.6
x | P/E ratio 2025 * |
11.4
x | Employees | 1,03,605 |
Yield 2024 * |
4.54% | Yield 2025 * |
4.7% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
1 day | +0.81% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 01/03/01 | |
Severin Schwan
CHM | Chairman | 57 | 01/08/01 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01/11/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03/15/03 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01/96/01 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.09% | 681B | |
+21.85% | 556B | |
-5.16% | 361B | |
+17.28% | 325B | |
+4.81% | 285B | |
+13.49% | 235B | |
+3.58% | 199B | |
-3.89% | 157B | |
+9.01% | 149B |
- Stock Market
- Equities
- ROG Stock
- RHO Stock